{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:39:20Z","timestamp":1791895160677,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Newcastle disease caused by ND virus (NDV) is a highly contagious disease of birds. Vaccine for effective protection of poultry animals from NDV infection is urgently needed. Mucosal immunity plays a very important role in the antiviral immune response. In this study, a NDV F gene-containing DNA vaccine encapsulated in Ag@SiO<jats:sub>2<\/jats:sub> hollow nanoparticles (pFDNA-Ag@SiO<jats:sub>2<\/jats:sub>-NPs) with an average diameter of 500\u2009nm were prepared to assess the mucosal immune response. These nanoparticles exhibited low cytotoxicity and did not destroy the bioactivity of plasmid DNA, which could be expressed <jats:italic>in vitro<\/jats:italic>. The plasmid DNA was sustainably released after an initial burst release. <jats:italic>In vivo<\/jats:italic> immunization showed that the intranasal immunization of chickens with pFDNA-Ag@SiO<jats:sub>2<\/jats:sub>-NPs induced high titers of serum antibody, significantly promoted lymphocyte proliferation and induced higher expression levels of IL-2 and IFN-\u03b3 in a dose-dependent manner. These results indicated that the Ag@SiO<jats:sub>2<\/jats:sub> hollow nanoparticles could serve as an efficient and safe delivery carrier for NDV DNA vaccine to induce mucosal immunity. This study has provided promising results for the further development of mucosal vaccines encapsulated in inorganic nanoparticles.<\/jats:p>","DOI":"10.1038\/srep25720","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T10:12:55Z","timestamp":1463047975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles"],"prefix":"10.1038","volume":"6","author":[{"given":"Kai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"key":"BFsrep25720_CR1","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/1743-422X-8-202","volume":"8","author":"J Yi","year":"2011","unstructured":"Yi, J. & Liu, C. Detecting Newcastle disease virus in combination of RT-PCR with red blood cell absorption. Virol J 8, 202\u2013206 (2011).","journal-title":"Virol J"},{"key":"BFsrep25720_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0378-1135(90)90140-Q","volume":"23","author":"DJ Alexander","year":"1990","unstructured":"Alexander, D. J. Avian Paramyxoviridae-recent developments. Vet Microbiol 23, 103\u2013114 (1990).","journal-title":"Vet Microbiol"},{"key":"BFsrep25720_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.vaccine.2007.11.032","volume":"26","author":"J Steel","year":"2008","unstructured":"Steel, J. et al. A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26, 522\u2013531 (2008).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR4","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1099\/vir.0.19416-0","volume":"84","author":"A Romer-Oberdorfer","year":"2003","unstructured":"Romer-Oberdorfer, A., Werner, O., Veits, J., Mebatsion, T. & Mettenleiter, T. C. Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J Gen Virol 84, 3121\u20133129 (2003).","journal-title":"J Gen Virol"},{"key":"BFsrep25720_CR5","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.1128\/JVI.00188-09","volume":"83","author":"Y Yan","year":"2009","unstructured":"Yan, Y., Rout, S. N., Kim, S. H. & Samal, S. K. Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus. J Virol 83, 5943\u20135946 (2009).","journal-title":"J Virol"},{"key":"BFsrep25720_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1590\/S0100-879X2008000400010","volume":"41","author":"S Chimeno Zoth","year":"2008","unstructured":"Chimeno Zoth, S., Gomez, E., Carrillo, E. & Berinstein, A. Locally produced mucosal IgG in chickens immunized with conventional vaccines for Newcastle disease virus. Braz J Med Biol Res 41, 318\u2013323 (2008).","journal-title":"Braz J Med Biol Res"},{"key":"BFsrep25720_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.addr.2005.01.013","volume":"57","author":"HS Garmory","year":"2005","unstructured":"Garmory, H. S., Perkins, S. D., Phillpotts, R. J. & Titball, R. W. DNA vaccines for biodefence. Adv Drug Deliv Rev 57, 1343\u20131361 (2005).","journal-title":"Adv Drug Deliv Rev"},{"key":"BFsrep25720_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.11599\/germs.2013.1034","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan, K. H. DNA vaccines: roles against diseases. Germs 3, 26\u201335 (2013).","journal-title":"Germs"},{"key":"BFsrep25720_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4161\/hv.7.12.17983","volume":"7","author":"G Wang","year":"2011","unstructured":"Wang, G., Pan, L. & Zhang, Y. Approaches to improved targeting of DNA vaccines. Hum Vaccin 7, 1271\u20131281 (2011).","journal-title":"Hum Vaccin"},{"key":"BFsrep25720_CR10","first-page":"188","volume":"2","author":"C Pachuk","year":"2000","unstructured":"Pachuk, C., McCallus, D., Weiner, D. & Satishchandran, C. DNA vaccines\u2013challenges in delivery. Curr Opin Mol Ther 2, 188\u2013198 (2000).","journal-title":"Curr Opin Mol Ther"},{"key":"BFsrep25720_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1385\/MB:17:2:143","volume":"17","author":"JS Robertson","year":"2001","unstructured":"Robertson, J. S. & Griffiths, E. Assuring the quality, safety, and efficacy of DNA vaccines. Mol Biotechnol 17, 143\u2013149 (2001).","journal-title":"Mol Biotechnol"},{"key":"BFsrep25720_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virusres.2009.06.012","volume":"145","author":"H Wu","year":"2009","unstructured":"Wu, H., Dennis, V. A., Pillai, S. R. & Singh, S. R. RSV fusion (F) protein DNA vaccine provides partial protection against viral infection. Virus Res 145, 39\u201347 (2009).","journal-title":"Virus Res"},{"key":"BFsrep25720_CR13","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.vaccine.2012.11.024","volume":"31","author":"J Sun","year":"2013","unstructured":"Sun, J. et al. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant. Vaccine 31, 472\u2013479 (2013).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.vaccine.2010.10.083","volume":"29","author":"D Halleng\u00e4rd","year":"2011","unstructured":"Halleng\u00e4rd, D. et al. Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity. Vaccine 29, 839\u2013848 (2011).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/vim.2010.0056","volume":"24","author":"K Xu","year":"2011","unstructured":"Xu, K. et al. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol 24, 45\u201356 (2011).","journal-title":"Viral Immunol"},{"key":"BFsrep25720_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408360490269251","volume":"41","author":"S Manoj","year":"2004","unstructured":"Manoj, S., Babiuk, L. A. & den Hurk, S. Approaches to enhance the efficacy of DNA vaccines. Crit Rev Clin Lab Sci 41, 1\u201339 (2004).","journal-title":"Crit Rev Clin Lab Sci"},{"key":"BFsrep25720_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/dna.2009.0862","volume":"28","author":"J Sun","year":"2009","unstructured":"Sun, J. et al. Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy. DNA Cell Biol 28, 233\u2013240 (2009).","journal-title":"DNA Cell Biol"},{"key":"BFsrep25720_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.addr.2006.09.010","volume":"58","author":"S Moghimi","year":"2006","unstructured":"Moghimi, S. & Kissel, T. Particulate nanomedicines. Adv Drug Del Rev 58, 1451\u20131455 (2006).","journal-title":"Adv Drug Del Rev"},{"key":"BFsrep25720_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/156720106778559029","volume":"3","author":"L Tao","year":"2006","unstructured":"Tao, L., Davies, M., Blanchfield, N. M., Toth, J. T. & I. Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Del 3, 379\u2013388 (2006).","journal-title":"Curr Drug Del"},{"key":"BFsrep25720_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.biomaterials.2013.09.060","volume":"35","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. The enhanced immune response of hepatitis B virus DNA vaccine using SiO2@LDH nanoparticles as an adjuvant. Biomaterials 35, 466\u2013478 (2014).","journal-title":"Biomaterials"},{"key":"BFsrep25720_CR21","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.3390\/ijms15057293","volume":"15","author":"BK Kim","year":"2014","unstructured":"Kim, B. K. et al. Efficient delivery of plasmid DNA using cholesterol-based cationic lipids containing polyamines and ether linkages. Int J Mol Sci 15, 7293\u20137312 (2014).","journal-title":"Int J Mol Sci"},{"key":"BFsrep25720_CR22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11427-012-4434-4","volume":"56","author":"F Zhao","year":"2013","unstructured":"Zhao, F. et al. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits. Sci China Life Sci 56, 174\u2013180 (2013).","journal-title":"Sci China Life Sci"},{"key":"BFsrep25720_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12250-012-3269-2","volume":"27","author":"RK Nanda","year":"2012","unstructured":"Nanda, R. K. et al. An effective mannosylated chitosan nanoparticle DNA vaccine for FMD virus. Virol Sin 27, 373\u2013376 (2012).","journal-title":"Virol Sin"},{"key":"BFsrep25720_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.biomaterials.2010.08.107","volume":"32","author":"A Li","year":"2011","unstructured":"Li, A. et al. The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response. Biomaterials 32, 469\u2013477 (2011).","journal-title":"Biomaterials"},{"key":"BFsrep25720_CR25","first-page":"163","volume":"2","author":"ZP Xu","year":"2007","unstructured":"Xu, Z. P. et al. Layered double hydroxide nanoparticles as cellular delivery vectors of supercoiled plasmid DNA. Int J Nanomedicine 2, 163\u2013174 (2007).","journal-title":"Int J Nanomedicine"},{"key":"BFsrep25720_CR26","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1021\/nl300027p","volume":"12","author":"L Xu","year":"2012","unstructured":"Xu, L. et al. Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment. Nano Lett 12, 2003\u20132012 (2012).","journal-title":"Nano Lett"},{"key":"BFsrep25720_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmv.21029","volume":"80","author":"X Wang","year":"2008","unstructured":"Wang, X., Uto, T., Akagi, T., Akashi, M. & Baba, M. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine. J Med Virol 80, 11\u201319 (2008).","journal-title":"J Med Virol"},{"key":"BFsrep25720_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/ceat.200406138","volume":"27","author":"J Bertling","year":"2004","unstructured":"Bertling, J., Bl\u00f6mer, J. & K\u00fcmmel, R. Hollow Microsperes. Chem Eng Tech 27, 829\u2013837 (2004).","journal-title":"Chem Eng Tech"},{"key":"BFsrep25720_CR29","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.2147\/IJN.S52239","volume":"8","author":"HC Chuang","year":"2013","unstructured":"Chuang, H. C. et al. Allergenicity and toxicology of inhaled silver nanoparticles in allergen-provocation mice models. Int J Nanomedicine 8, 4495\u20134506 (2013).","journal-title":"Int J Nanomedicine"},{"key":"BFsrep25720_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.colsurfb.2009.07.048","volume":"74","author":"S Gurunathan","year":"2009","unstructured":"Gurunathan, S. et al. Biosynthesis, purification and characterization of silver nanoparticles using Escherichia coli . Colloids Surf B Biointerfaces 74, 328\u2013335 (2009).","journal-title":"Colloids Surf B Biointerfaces"},{"key":"BFsrep25720_CR31","first-page":"220","volume":"2","author":"M Kalaiselvi","year":"2013","unstructured":"M. Kalaiselvi & R. S. Masilamani Selvam. Synthesis and characterization of silver nanoparticles from leaf extract of Parthenium hysterophorus and its anti-bacterial and antioxidant activity. Int J Curr Micro Appl Sci 2, 220\u2013227 (2013).","journal-title":"Int J Curr Micro Appl Sci"},{"key":"BFsrep25720_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jconrel.2012.04.015","volume":"161","author":"SD Jazayeri","year":"2012","unstructured":"Jazayeri, S. D. et al. Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles. J Control Release 161, 116\u2013123 (2012).","journal-title":"J Control Release"},{"key":"BFsrep25720_CR33","first-page":"4631","volume":"8","author":"W Ding","year":"2013","unstructured":"Ding, W. & Guo, L. Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery. Int J Nanomedicine 8, 4631\u20134639 (2013).","journal-title":"Int J Nanomedicine"},{"key":"BFsrep25720_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-9-1","volume":"9","author":"HC Guo","year":"2012","unstructured":"Guo, H. C. et al. Immunization of mice by hollow mesoporous silica nanoparticles as carriers of Porcine circovirus type 2 ORF2 protein. Virol J 9, 1\u201310 (2012).","journal-title":"Virol J"},{"key":"BFsrep25720_CR35","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1039\/C5SC03847B","volume":"7","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. Robust vaccine formulation produced by assembling a hybrid coating of polyethyleneimine\u2013silica. Chem Sci 7, 1753\u20131759 (2016).","journal-title":"Chem Sci"},{"key":"BFsrep25720_CR36","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1021\/nn5063276","volume":"9","author":"G Wang","year":"2015","unstructured":"Wang, G. et al. Hydrated silica exterior produced by biomimetic silicification confers viral vaccine heat-resistance. ACS Nano 9, 799\u2013808 (2015).","journal-title":"ACS Nano"},{"key":"BFsrep25720_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cis.2013.12.008","volume":"209","author":"K Chatterjee","year":"2014","unstructured":"Chatterjee, K., Sarkar, S., Jagajjanani Rao, K. & Paria, S. Core\/shell nanoparticles in biomedical applications. Adv Colloid Interfac 209, 8\u201339 (2014).","journal-title":"Adv Colloid Interfac"},{"key":"BFsrep25720_CR38","doi-asserted-by":"publisher","first-page":"8549","DOI":"10.1016\/j.vaccine.2011.09.029","volume":"29","author":"K Zhao","year":"2011","unstructured":"Zhao, K. et al. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 29, 8549\u20138556 (2011).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/IJN.S54226","volume":"9","author":"K Zhao","year":"2014","unstructured":"Zhao, K. et al. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int J nanomedicine 9, 389\u2013402 (2014).","journal-title":"Int J nanomedicine"},{"key":"BFsrep25720_CR40","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1128\/IAI.73.5.2863-2872.2005","volume":"73","author":"R Wang","year":"2005","unstructured":"Wang, R. et al. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect Immun. 73, 2863\u20132872 (2005).","journal-title":"Infect Immun."},{"key":"BFsrep25720_CR41","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1099\/vir.0.80822-0","volume":"86","author":"OS de Leeuw","year":"2005","unstructured":"de Leeuw, O. S., Koch, G., Hartog, L., Ravenshorst, N. & Peeters, B. P. Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein. J Gen Virol 86, 1759\u20131769 (2005).","journal-title":"J Gen Virol"},{"key":"BFsrep25720_CR42","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0142-9612(00)00134-4","volume":"21","author":"S Senel","year":"2000","unstructured":"Senel, S. et al. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21, 2067\u20132071 (2000).","journal-title":"Biomaterials"},{"key":"BFsrep25720_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0939-6411(00)00084-9","volume":"50","author":"T Jung","year":"2000","unstructured":"Jung, T. et al. Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 50, 147\u2013160 (2000).","journal-title":"Eur J Pharm Biopharm"},{"key":"BFsrep25720_CR44","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.addr.2007.06.003","volume":"59","author":"JK Vasir","year":"2007","unstructured":"Vasir, J. K. & Labhasetwar, V. Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 59, 718\u2013728 (2007).","journal-title":"Adv Drug Deliv Rev"},{"key":"BFsrep25720_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nano.2009.02.004","volume":"5","author":"S Boyoglu","year":"2009","unstructured":"Boyoglu, S. et al. Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virus. Nanomedicine 5, 463\u2013472 (2009).","journal-title":"Nanomedicine"},{"key":"BFsrep25720_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tice.2012.12.001","volume":"45","author":"M Nasrin","year":"2013","unstructured":"Nasrin, M., Khan, M. Z. I., Siddiqi, M. N. H. & Masum, M. A. Mobilization of immunoglobulin (Ig)-containing plasma cells in Harderian gland, cecal tonsil and trachea of broilers vaccinated with Newcastle Disease Vaccine. Tissue Cell 45, 191\u2013197 (2013).","journal-title":"Tissue Cell"},{"key":"BFsrep25720_CR47","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/01926230600865531","volume":"34","author":"MF Cesta","year":"2006","unstructured":"Cesta, M. F. Normal structure, function, and histology of mucosa-associated lymphoid tissue. Toxicol Pathol 34, 599\u2013608 (2006).","journal-title":"Toxicol Pathol"},{"key":"BFsrep25720_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0042-6822(81)90474-8","volume":"109","author":"DC Merz","year":"1981","unstructured":"Merz, D. C., Scheid, A. & Choppin, P. W. Immunological studies of the functions of paramyxovirus glycoproteins. Virology 109, 94\u2013105 (1981).","journal-title":"Virology"},{"key":"BFsrep25720_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/03079459308418897","volume":"22","author":"HS Lillehoj","year":"1993","unstructured":"Lillehoj, H. S. & Trout, J. M. Coccidia: a review of recent advances on immunity and vaccine development. Avian Pathol 22, 3\u201331 (1993).","journal-title":"Avian Pathol"},{"key":"BFsrep25720_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0897.2010.00954.x","volume":"65","author":"PF Wright","year":"2011","unstructured":"Wright, P. F. Inductive\/effector mechanisms for humoral immunity at mucosal sites. Am J Reprod Immunol 65, 248\u2013252 (2011).","journal-title":"Am J Reprod Immunol"},{"key":"BFsrep25720_CR51","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","volume":"79","author":"T Ichinohe","year":"2005","unstructured":"Ichinohe, T. et al. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J Virol 79, 2910\u20132919 (2005).","journal-title":"J Virol"},{"key":"BFsrep25720_CR52","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/eji.1830220228","volume":"22","author":"SI Tamura","year":"1992","unstructured":"Tamura, S. I. et al. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine. Eur J Immunol 22, 477\u2013481 (1992).","journal-title":"Eur J Immunol"},{"key":"BFsrep25720_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1128\/CVI.00263-10","volume":"18","author":"J Xu","year":"2011","unstructured":"Xu, J. et al. Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae . Clin Vaccine Immunol 18, 75\u201381 (2011).","journal-title":"Clin Vaccine Immunol"},{"key":"BFsrep25720_CR54","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","volume":"25","author":"P Brandtzaeg","year":"2007","unstructured":"Brandtzaeg, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467\u20135484 (2007).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","volume":"21","author":"J Smith","year":"2004","unstructured":"Smith, J., Wood, E. & Dornish, M. Effect of chitosan on epithelial cell tight junctions. Pharm Res 21, 43\u201349 (2004).","journal-title":"Pharm Res"},{"key":"BFsrep25720_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0955-2863(01)00208-X","volume":"13","author":"G Ranaldi","year":"2002","unstructured":"Ranaldi, G., Marigliano, I., Vespignani, I., Perozzi, G. & Sambuy, Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line. J Nutr Biochem 13, 157\u2013167 (2002).","journal-title":"J Nutr Biochem"},{"key":"BFsrep25720_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao, L. et al. Nanoparticle vaccines. Vaccine 32, 327\u2013337 (2014).","journal-title":"Vaccine"},{"key":"BFsrep25720_CR58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.coviro.2011.08.003","volume":"1","author":"NA Hutnick","year":"2011","unstructured":"Hutnick, N. A., Myles, D. J., Bian, C. B., Muthumani, K. & Weiner, D. B. Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo . Curr Opin Virol 1, 233\u2013240 (2011).","journal-title":"Curr Opin Virol"},{"key":"BFsrep25720_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0145-305X(99)00067-1","volume":"24","author":"MA Qureshi","year":"2000","unstructured":"Qureshi, M. A., Heggen, C. L. & Hussain, I. Avian macrophage: effector functions in health and disease. Dev Comp Immunol 24, 103\u2013119 (2000).","journal-title":"Dev Comp Immunol"},{"key":"BFsrep25720_CR60","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1016\/S0167-577X(03)00344-6","volume":"57","author":"J Zhang","year":"2003","unstructured":"Zhang, J., Chen, Z., Wang, Z., Zhang, W. & Ming, N. Preparation of monodisperse polystyrene spheres in aqueous alcohol system. Mater Lett 57, 4466\u20134470 (2003).","journal-title":"Mater Lett"},{"key":"BFsrep25720_CR61","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1021\/jp067077f","volume":"111","author":"C Tian","year":"2007","unstructured":"Tian, C. et al. Simple strategy for preparation of core colloids modified with metal nanoparticles. J Phys Chem C 111, 3651\u20133657 (2007).","journal-title":"J Phys Chem C"},{"key":"BFsrep25720_CR62","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1021\/cm900874u","volume":"21","author":"L Li","year":"2009","unstructured":"Li, L., Ding, J. & Xue, J. Macroporous silica hollow microspheres as nanoparticle collectors. Chem Mater 21, 3629\u20133637 (2009).","journal-title":"Chem Mater"},{"key":"BFsrep25720_CR63","first-page":"8","volume":"17","author":"W Zeng","year":"2009","unstructured":"Zeng, W., Wang, Y. & Shi, X. Optimization of codon usage of F gene enhanced efficacy of Newcastle disease virus DNA vaccine. Chin J Anim Infecti Dis 17, 8\u201316 (2009).","journal-title":"Chin J Anim Infecti Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep25720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T06:21:43Z","timestamp":1672899703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep25720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,5,27]]}},"alternative-id":["BFsrep25720"],"URL":"https:\/\/doi.org\/10.1038\/srep25720","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]},"assertion":[{"value":"13 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25720"}}